PHARMACYTE BIOTECH, INC. Cost of Revenue
PHARMACYTE BIOTECH, INC. (PMCB) reported Cost of Revenue of $0 for the 3-month period ending 2017-04-30, per its 10-K filed 2017-07-27.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2017-07-27
- PHARMACYTE BIOTECH, INC. cost of revenue for the quarter ending 2017-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for the quarter ending 2017-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for the quarter ending 2016-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for the quarter ending 2016-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for fiscal 2016 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for fiscal 2015 was $0.00.
- PHARMACYTE BIOTECH, INC. cost of revenue for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- PHARMACYTE BIOTECH, INC. cost of revenue for fiscal 2013 was $9.62K, a 50.37% decline from fiscal 2012.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2017-04-30 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2017-01-31 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 10-Q · filed 2017-03-13 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-10-31 | $0.00 10-K · filed 2017-07-27 | $0.00 10-Q · filed 2016-12-02 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-07-31 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-04-30 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 10-K · filed 2016-07-29 |
| 2016-01-31 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 10-Q · filed 2017-03-13 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2015-10-31 | $0.00 10-K · filed 2017-07-27 | $0.00 10-Q · filed 2016-12-02 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2015-07-31 | $0.00 10-K · filed 2017-07-27 | $0.00 derived: sum of 2 quarters · filed 2017-07-27 | $0.00 derived: sum of 3 quarters · filed 2017-07-27 | $0.00 derived: sum of 4 quarters · filed 2017-07-27 |
| 2015-04-30 | $0.00 10-K · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 10-K · filed 2016-07-29 |
| 2015-01-31 | $0.00 10-K · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 10-Q · filed 2016-03-08 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-10-31 | $0.00 10-K · filed 2016-07-29 | $0.00 10-Q/A · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-07-31 | $0.00 10-K · filed 2016-07-29 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 derived: sum of 3 quarters · filed 2016-07-29 | $0.00 derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-04-30 | $0.00 10-K/A · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 10-K · filed 2016-07-29 |
| 2014-01-31 | $0.00 10-K/A · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 10-Q · filed 2015-03-13 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-10-31 | $0.00 10-K/A · filed 2016-01-19 | $0.00 10-Q · filed 2014-12-15 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $0.00 derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-07-31 | $0.00 10-K/A · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $0.00 derived: sum of 3 quarters · filed 2016-01-19 | $9.62K derived: sum of 4 quarters · filed 2016-01-19 |
| 2013-04-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $0.00 derived: sum of 2 quarters · filed 2016-01-19 | $9.62K derived: sum of 3 quarters · filed 2016-01-19 | $9.62K 10-K/A · filed 2016-01-19 |
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $9.62K derived: sum of 2 quarters · filed 2014-03-17 | $9.62K 10-Q · filed 2014-03-17 | $5.08K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-10-31 | $9.62K 10-Q · filed 2013-12-16 | $9.62K 10-Q · filed 2013-12-16 | $5.08K derived: sum of 3 quarters · filed 2013-12-16 | $7.29K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | $0.00 10-Q · filed 2013-09-16 | -$4.54K derived: sum of 2 quarters · filed 2013-09-16 | -$2.33K derived: sum of 3 quarters · filed 2013-09-16 | $3.71K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | -$4.54K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$2.33K derived: sum of 2 quarters · filed 2013-07-29 | $3.71K derived: sum of 3 quarters · filed 2013-07-29 | $19.38K 10-K · filed 2013-07-29 |
| 2012-01-31 | $2.21K 10-Q · filed 2013-03-26 | $8.25K derived: sum of 2 quarters · filed 2013-03-26 | $23.92K 10-Q · filed 2013-03-26 | $24.27K derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | $6.04K 10-Q · filed 2012-12-26 | $21.71K 10-Q · filed 2012-12-26 | $22.05K derived: sum of 3 quarters · filed 2012-12-26 | $44.03K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | $15.68K 10-Q · filed 2012-09-19 | $16.02K derived: sum of 2 quarters · filed 2012-09-19 | $38.00K derived: sum of 3 quarters · filed 2012-09-19 | $40.85K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | $343.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $22.32K derived: sum of 2 quarters · filed 2012-08-14 | $25.18K derived: sum of 3 quarters · filed 2012-08-14 | $32.10K 10-K · filed 2012-08-14 |
| 2011-01-31 | $21.98K 10-Q · filed 2012-03-21 | $24.83K derived: sum of 2 quarters · filed 2012-03-21 | $31.76K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | $2.85K 10-Q · filed 2011-12-15 | $9.78K 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | $6.93K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |